Bisoprolol in cardiovascular disease treatment

Literature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac arrhythmias. The main clinical trials, proving...

Full description

Saved in:
Bibliographic Details
Main Authors: S. N. Tolpygina, S. Yu. Martsevich
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1689
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342318163787776
author S. N. Tolpygina
S. Yu. Martsevich
author_facet S. N. Tolpygina
S. Yu. Martsevich
author_sort S. N. Tolpygina
collection DOAJ
description Literature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac arrhythmias. The main clinical trials, proving beneficial survival effects of BAB in CVD patients, are briefly described. The authors present the results of their original comparative pharmaco-economic study on clinical equivalence of original and generic bisoprolol in AH treatment. Original medication was more effective than generic one, with similar tolerability of both bisoprolol forms.
format Article
id doaj-art-c1ef2c29b9694ca09cc321a5d0c2e51e
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2008-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-c1ef2c29b9694ca09cc321a5d0c2e51e2025-08-20T03:43:26Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-01771111181407Bisoprolol in cardiovascular disease treatmentS. N. Tolpygina0S. Yu. Martsevich1State Research Center for Preventive Medicine, Federal Agency on High Medical Technologies. MoscowState Research Center for Preventive Medicine, Federal Agency on High Medical Technologies. MoscowLiterature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac arrhythmias. The main clinical trials, proving beneficial survival effects of BAB in CVD patients, are briefly described. The authors present the results of their original comparative pharmaco-economic study on clinical equivalence of original and generic bisoprolol in AH treatment. Original medication was more effective than generic one, with similar tolerability of both bisoprolol forms.https://cardiovascular.elpub.ru/jour/article/view/1689bisoprololcoronary heart diseasechronic heart failurearterial hypertensionoriginal and generic medications
spellingShingle S. N. Tolpygina
S. Yu. Martsevich
Bisoprolol in cardiovascular disease treatment
Кардиоваскулярная терапия и профилактика
bisoprolol
coronary heart disease
chronic heart failure
arterial hypertension
original and generic medications
title Bisoprolol in cardiovascular disease treatment
title_full Bisoprolol in cardiovascular disease treatment
title_fullStr Bisoprolol in cardiovascular disease treatment
title_full_unstemmed Bisoprolol in cardiovascular disease treatment
title_short Bisoprolol in cardiovascular disease treatment
title_sort bisoprolol in cardiovascular disease treatment
topic bisoprolol
coronary heart disease
chronic heart failure
arterial hypertension
original and generic medications
url https://cardiovascular.elpub.ru/jour/article/view/1689
work_keys_str_mv AT sntolpygina bisoprololincardiovasculardiseasetreatment
AT syumartsevich bisoprololincardiovasculardiseasetreatment